Practice Management
The Food and Drug Administration (FDA) this week approved a blood test for colorectal cancer screening in average-risk adults aged 45 and older. Known as Shield, it is the first blood test to receive FDA approval as a primary screening method for colorectal cancer and to qualify for Medicare reimbursement, according to a press release. While the price has not been announced, the test is expected to reach the market within a week. Shield will …
Read More
The Food And Drug Administration recently approved a device that provides non-invasive skin cancer screening at the point of care, according to Reuters. DermaSensor, a privately held company, says its spectroscopy technology can use light and artificial intelligence to evaluate cellular and subcellular characteristics to assist clinicians in identifying the presence of skin cancer in suspicious moles or lesions. A study by the Mayo Clinic of more than 1,000 patients showed that the device had …
Read More